DE69200840D1 - Harnstoff- und Thioharnstoffderivate, Herstellung und therapeutische Verwendung. - Google Patents

Harnstoff- und Thioharnstoffderivate, Herstellung und therapeutische Verwendung.

Info

Publication number
DE69200840D1
DE69200840D1 DE69200840T DE69200840T DE69200840D1 DE 69200840 D1 DE69200840 D1 DE 69200840D1 DE 69200840 T DE69200840 T DE 69200840T DE 69200840 T DE69200840 T DE 69200840T DE 69200840 D1 DE69200840 D1 DE 69200840D1
Authority
DE
Germany
Prior art keywords
urea
manufacture
therapeutic use
thiourea derivatives
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69200840T
Other languages
English (en)
Other versions
DE69200840T2 (de
Inventor
Jean-Louis Vidaluc
Denis Bigg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE69200840D1 publication Critical patent/DE69200840D1/de
Publication of DE69200840T2 publication Critical patent/DE69200840T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69200840T 1991-02-14 1992-02-12 Harnstoff- und Thioharnstoffderivate, Herstellung und therapeutische Verwendung. Expired - Fee Related DE69200840T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9101740A FR2672888B1 (fr) 1991-02-14 1991-02-14 Nouvelles urees et thiourees, leur preparation et leur application en therapeutique.
PCT/FR1992/000131 WO1992014710A1 (fr) 1991-02-14 1992-02-12 Nouvelles urees et thiourees, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
DE69200840D1 true DE69200840D1 (de) 1995-01-19
DE69200840T2 DE69200840T2 (de) 1995-06-29

Family

ID=9409713

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69200840T Expired - Fee Related DE69200840T2 (de) 1991-02-14 1992-02-12 Harnstoff- und Thioharnstoffderivate, Herstellung und therapeutische Verwendung.

Country Status (9)

Country Link
EP (1) EP0571511B1 (de)
JP (1) JPH06507387A (de)
AT (1) ATE115131T1 (de)
DE (1) DE69200840T2 (de)
DK (1) DK0571511T3 (de)
ES (1) ES2066605T3 (de)
FR (1) FR2672888B1 (de)
GR (1) GR3015132T3 (de)
WO (1) WO1992014710A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1891954A3 (de) 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Wirkstoffe zur Verbesserung der Exkretionskraft der Harnblase
US6962926B2 (en) 2001-01-31 2005-11-08 Telik, Inc. Antagonist of MCP-1 function, and compositions and methods of use thereof
US6670364B2 (en) 2001-01-31 2003-12-30 Telik, Inc. Antagonists of MCP-1 function and methods of use thereof
TWI245761B (en) 2001-03-01 2005-12-21 Telik Inc Antagonists of MCP-1 function and methods of use thereof
US6677365B2 (en) 2001-04-03 2004-01-13 Telik, Inc. Antagonists of MCP-1 function and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne

Also Published As

Publication number Publication date
GR3015132T3 (en) 1995-05-31
ATE115131T1 (de) 1994-12-15
DE69200840T2 (de) 1995-06-29
JPH06507387A (ja) 1994-08-25
FR2672888A1 (fr) 1992-08-21
DK0571511T3 (da) 1995-05-08
EP0571511B1 (de) 1994-12-07
WO1992014710A1 (fr) 1992-09-03
ES2066605T3 (es) 1995-03-01
FR2672888B1 (fr) 1994-02-04
EP0571511A1 (de) 1993-12-01

Similar Documents

Publication Publication Date Title
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
BR9507917A (pt) Reagente para preparar um agente radiofarmacêutico agente formador de imagem processo para preparar o mesmo kit para preparar uma preparação farmacêutica uso do reagente agente radioterapêutico composição e agente radiofarmacêutico
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ES2132393T3 (es) Derivados de guanidina utiles en terapeutica.
MX9707453A (es) Derivados de quinazolina.
ES2151156T3 (es) Derivados de acidos n-(aroil)glicina hidroxamicos y compuestos relacionados.
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
HK1013993A1 (en) Novel carbamates and ureas as modifiers of multi-drug resistance
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
SE9702564D0 (sv) New compounds
ATE211729T1 (de) Therapeutisch wirksame verbindungen
ATE115131T1 (de) Harnstoff- und thioharnstoffderivate, herstellung und therapeutische verwendung.
BR9304780A (pt) Composto, processo para preparar o composto, composição farmacêutica e uso
DE69419954T2 (de) Arzneimittel zur Behandlung von Hauterkrankungen
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
IT1223395B (it) Composti ad attivita' cardiovascolare
ATE44875T1 (de) 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln.
ATE192650T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE136217T1 (de) Verwendung von imino-derivaten von etianaldehyd zur herstellung eines arzneimittels zur behandlung des bluthochdrucks
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
FI894813A (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
DE3884878D1 (de) Uricosuretische Zusammensetzung.
FI850593L (fi) N-(2,6-disubstituerade aromatiska) -n'-pyridinylureafoereningar.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee